File:Mainz.BioNTechSE.20200731.jpg · Wikimedia Commons · See Wikimedia Commons
BioNTech
Sign in to saveAlso known as Biopharmaceutical New Technologies, BioNTech SE, BioNTech AG, BNT, BNTX
BioNTech SE ( ; or short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Key facts
- Company.name
- BioNTech SE
- Company.logo
- BioNTech logo.svg
- Company.image
- Mainz.BioNTechSE.20200731.jpg
- Company.image_caption
- Headquarters in Mainz
- Company.type
- Public company
- Company.industry
- Biotechnology
- Company.hq_location_city
- Mainz
- Company.hq_location_country
- Germany
- Company.num_locations
- 17
- Company.num_locations_year
- 2024
- Company.area_served
- Worldwide
- Company.products
- Pfizer-BioNTech COVID-19 vaccine, Immunotherapy and vaccine candidates
- Company.services
- Immunotherapy
- Company.revenue
- billion
- Company.revenue_year
- 2025
- Company.operating_income
- €−1.40 billion
- Company.income_year
- 2025
- Company.net_income
- €−1.14 billion
via Wikipedia infobox
Company
BNTX- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- Nasdaq
- State of incorporation
- 2M
- Entity type
- other
- Latest filing
- 6-K · 2026-06-01
- Jurisdiction
- DE
- Headquarters
- Mainz, DE
Research organization · ROR
- Type
- Company
- Founded
- 2008
- Location
- Mainz, Germany
- Also known as
- Biopharmaceutical New Technologies
- Status
- Active
GRID grid.434484.b · ISNI 0000 0004 4692 2203
Official website
BioNTech
BioNTech führt Sie durch die spannende Welt der Immuntherapien. Hier finden Sie Informationen zur Grundlagenforschung und zu neuartigen Behandlungsmöglichkeiten.
biontech.de →Link to the official site · 10,522 chars · not written by Vinony
Wikidata facts
- Official name
- BioNTech AG
- Employees
- 1300
- Revenue
- 61598000
- Official website
- biontech.de
- Image
- Mainz.BioNTechSE.20200731.jpg
Show 7 more facts
- inception
- 2008-06-00
- Commons category
- BioNTech
- net profit
- -85950000
- total assets
- 374713000
- operating income
- -61277000
- total equity
- -48206000
- social media followers
- 82448
Sources (8)
via Wikidata · CC0
~11 min read
Article
18 sectionsContents
- History
- Foundation (2008–2014)
- Expansion, Series A financing (2015–2018)
- Series B financing and Nasdaq IPO (2019)
- COVID-19 (since 2020)
- Oncology and international expansion (since 2021)
- Company structure
- Locations
- Management Board
- Therapeutic areas
- Oncology
- Infectious diseases
- Criticism
- Influence by the Chinese government
- Pricing of the COVID vaccine
- See also
- References
- External links
BioNTech
Gallery (3)
On the map
14 mapped locations